Shilpa Medicare

62
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
850.50
-50.4 (-5.59%)
BSENSE

Nov 20

BSE+NSE Vol: 16.58 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
1,538.00
1,286.00
1,151.00
1,050.00
1,145.00
901.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,538.00
1,286.00
1,151.00
1,050.00
1,145.00
901.00
Expenditure (Ex Depriciation)
Stock Adjustments
-36.00
37.00
-34.00
14.00
-7.00
-58.00
Raw Materials Consumed
496.00
372.00
442.00
401.00
390.00
329.00
Power & Fuel Cost
59.00
53.00
52.00
56.00
52.00
40.00
Employee Cost
334.00
292.00
281.00
286.00
264.00
235.00
Operating Expenses
82.00
62.00
49.00
58.00
62.00
53.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
41.00
20.00
15.00
14.00
25.00
18.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
-17.00
15.00
18.00
12.00
20.00
15.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,104.00
967.00
907.00
947.00
941.00
719.00
Operating Profit (PBDIT) excl Other Income
434.00
319.00
244.00
102.00
203.00
181.00
Other Income
9.00
23.00
8.00
17.00
14.00
30.00
Operating Profit (PBDIT)
444.00
342.00
252.00
119.00
218.00
211.00
Interest
58.00
75.00
91.00
58.00
41.00
21.00
Profit before Depriciation and Tax
385.00
267.00
160.00
61.00
176.00
189.00
Depreciation
119.00
112.00
107.00
95.00
79.00
53.00
Profit Before Taxation & Exceptional Items
266.00
154.00
52.00
-34.00
97.00
135.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
295.00
122.00
54.00
-38.00
102.00
195.00
Provision for Tax
51.00
44.00
22.00
-7.00
41.00
48.00
Profit After Tax
226.00
79.00
36.00
-27.00
64.00
147.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,087.00
1,033.00
1,001.00
1,043.00
991.00
842.00
Profit Available for appropriations
1,330.00
1,112.00
1,033.00
1,010.00
1,052.00
990.00
Appropriations
1,330.00
1,112.00
1,033.00
1,010.00
1,052.00
990.00
Equity Dividend (%)
60.00%
100.00%
0.00%
0.00%
110.00%
110.00%
Earnings Per Share
12.44
4.02
3.67
-3.75
7.26
18.13
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 19.62% vs 11.71% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 36.11% vs 30.62% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -22.16% vs -17.73% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 184.33% vs 116.59% in Mar 2025

Compare Profit and Loss Results of Shilpa Medicare
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,538.00
1,421.00
117.00
8.23%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,538.00
1,421.00
117.00
8.23%
Expenditure (Ex Depriciation)
Stock Adjustments
-36.00
7.00
-43.00
-614.29%
Raw Materials Consumed
496.00
436.00
60.00
13.76%
Power & Fuel Cost
59.00
37.00
22.00
59.46%
Employee Cost
334.00
242.00
92.00
38.02%
Operating Expenses
82.00
125.00
-43.00
-34.40%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
41.00
9.00
32.00
355.56%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
-17.00
-8.00
-9.00
-112.50%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,104.00
1,117.00
-13.00
-1.16%
Operating Profit (PBDIT) excl Other Income
434.00
304.00
130.00
42.76%
Other Income
9.00
15.00
-6.00
-40.00%
Operating Profit (PBDIT)
444.00
319.00
125.00
39.18%
Interest
58.00
122.00
-64.00
-52.46%
Profit before Depriciation and Tax
385.00
197.00
188.00
95.43%
Depreciation
119.00
279.00
-160.00
-57.35%
Profit Before Taxation & Exceptional Items
266.00
-82.00
348.00
424.39%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
295.00
-91.00
386.00
424.18%
Provision for Tax
51.00
-18.00
69.00
383.33%
Profit After Tax
226.00
-73.00
299.00
409.59%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,087.00
-1,843.00
2,930.00
158.98%
Profit Available for appropriations
1,330.00
-1,917.00
3,247.00
169.38%
Appropriations
1,330.00
-1,917.00
3,247.00
169.38%
Equity Dividend (%)
60%
0%
60.00
Earnings Per Share
12.44
-6.44
18.88
293.17%
Profit And Loss - Net Sales
Net Sales 1,538.87 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 19.62% vs 11.71% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 434.70 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 36.11% vs 30.62% in Mar 2025

Profit And Loss - Interest
Interest 58.79 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -22.16% vs -17.73% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 226.21 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 184.33% vs 116.59% in Mar 2025